Details
Stereochemistry | ACHIRAL |
Molecular Formula | C6H10S |
Molecular Weight | 114.209 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
C=CCSCC=C
InChI
InChIKey=UBJVUCKUDDKUJF-UHFFFAOYSA-N
InChI=1S/C6H10S/c1-3-5-7-6-4-2/h3-4H,1-2,5-6H2
Molecular Formula | C6H10S |
Molecular Weight | 114.209 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Allyl sulfide or diallyl sulfide, a natural organosulfur compound, which is mostly obtained from the genus Allium plants, exhibits anticancer activities. This compound also possesses a protective role in cisplatin-induced nephrotoxicity via suppressing NF-κB downstream inflammatory proteins and p53/Puma signaling pathway. Besides, diallyl sulfide exerts protective properties in experimental Inflammatory bowel disease (IBD), an incurable disease which affects millions of people. It was also discovered, that diallyl sulfide may be effective in reducing ethanol-induced injury of cells thereby suggesting its potential to be used in drug formulations.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: p53/Puma signaling pathway Sources: https://www.ncbi.nlm.nih.gov/pubmed/29266336 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Preventing | Unknown Approved UseUnknown |
|||
Preventing | Unknown Approved UseUnknown |
PubMed
Title | Date | PubMed |
---|---|---|
A pleiotropic response to phenobarbital-type enzyme inducers in the F344/NCr rat. Effects of chemicals of varied structure. | 1992 Mar 3 |
|
Activation of cytochrome P450 gene expression in the rat brain by phenobarbital-like inducers. | 2000 Sep |
|
Relative activities of organosulfur compounds derived from onions and garlic in increasing tissue activities of quinone reductase and glutathione transferase in rat tissues. | 2001 |
|
Inhibition of carcinogenesis and toxicity by dietary constituents. | 2001 |
|
Antioxidants in chemoprevention of skin cancer. | 2001 |
|
Removal of glutathione produces apoptosis and necrosis in HepG2 cells overexpressing CYP2E1. | 2001 Apr |
|
Effects of the garlic compound diallyl disulfide on the metabolism, adherence and cell cycle of HT-29 colon carcinoma cells: evidence of sensitive and resistant sub-populations. | 2001 Aug |
|
Cytochrome P4502E1 induction increases thioacetamide liver injury in diet-restricted rats. | 2001 Aug |
|
Antimutagenic activity of organosulfur compounds from Allium is associated with phase II enzyme induction. | 2001 Aug 22 |
|
[Status of and prospect on experimental studies of single Chinese herb inducing tumor cell apoptosis]. | 2001 Jan |
|
Ethanol enhances retinoic acid metabolism into polar metabolites in rat liver via induction of cytochrome P4502E1. | 2001 Jan |
|
CYP2E1-dependent toxicity and up-regulation of antioxidant genes. | 2001 Jan-Feb |
|
In-vitro antimicrobial activity of four diallyl sulphides occurring naturally in garlic and Chinese leek oils. | 2001 Jul |
|
Screening of organosulfur compounds as inhibitors of human CYP2A6. | 2001 Jul |
|
Diallyl sulfide--a flavour component from garlic (Allium sativum) attenuates lipid peroxidation in mice infected with Trichinella spiralis. | 2001 May |
|
In vitro activity of garlic oil and four diallyl sulphides against antibiotic-resistant Pseudomonas aeruginosa and Klebsiella pneumoniae. | 2001 May |
|
Anti-tumour-promoting action of Allium constituents. | 2002 |
|
Use of factorial designs to optimize animal experiments and reduce animal use. | 2002 |
|
In vivo effect of diallyl sulfide and cimetidine on phenacetin metabolism and bioavailability in rat. | 2002 |
|
Spontaneous oxidative stress and liver tumors in mice lacking methionine adenosyltransferase 1A. | 2002 Aug |
|
Inhibition of human low density lipoprotein oxidation by active principles from spices. | 2002 Jan |
|
Effect of naturally occurring organosulfur compounds on nitric oxide production in lipopolysaccharide-activated macrophages. | 2002 Jun 14 |
|
Inhibition of heterocyclic aromatic amine formation in fried ground beef patties by garlic and selected garlic-related sulfur compounds. | 2002 Nov |
|
Effect of garlic on cardiovascular disorders: a review. | 2002 Nov 19 |
|
Cytochrome P450 phenotypic ratios for predicting herb-drug interactions in humans. | 2002 Sep |
|
Enhancement of glutathione and g-glutamylcysteine synthetase, the rate limiting enzyme of glutathione synthesis, by chemoprotective plant-derived food and beverage components in the human hepatoma cell line HepG2. | 2003 |
|
Short-term acetaldehyde exposure depresses ventricular myocyte contraction: role of cytochrome P450 oxidase, xanthine oxidase, and lipid peroxidation. | 2003 Apr |
|
Interactions of herbs with cytochrome P450. | 2003 Feb |
|
The combined effects of garlic oil and fish oil on the hepatic antioxidant and drug-metabolizing enzymes of rats. | 2003 Feb |
|
Cytochrome P450 2E1 responsiveness in the promoter of glutamate-cysteine ligase catalytic subunit. | 2003 Jan |
|
Protective action on human LDL against oxidation and glycation by four organosulfur compounds derived from garlic. | 2003 Mar |
|
Comparative study of extraction techniques for determination of garlic flavor components by gas chromatography-mass spectrometry. | 2003 Oct |
|
Inhibition by allyl sulfides and phenethyl isothiocyanate of methyl-n-pentylnitrosamine depentylation by rat esophageal microsomes, human and rat CYP2E1, and Rat CYP2A3. | 2004 |
|
Garlic metabolites fail to inhibit the activation of the transcription factor NF-kappaB and subsequent expression of the adhesion molecule E-selectin in human endothelial cells. | 2004 Feb |
|
Inhibition of N-acetyltransferase activity and gene expression in human colon cancer cell lines by diallyl sulfide. | 2004 Feb |
|
Reversal of P-glycoprotein-mediated multidrug resistance by diallyl sulfide in K562 leukemic cells and in mouse liver. | 2004 Jun |
|
Inhibitory activity of essential oils of garlic and onion against bacteria and yeasts. | 2004 Mar |
|
Signal transduction pathways leading to cell cycle arrest and apoptosis induction in cancer cells by Allium vegetable-derived organosulfur compounds: a review. | 2004 Nov 2 |
|
Role of chemopreventive agents in cancer therapy. | 2004 Nov 25 |
|
Involvement of cytochrome P450 2E1 in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse model of Parkinson's disease. | 2004 Oct |
|
Garlic's ability to prevent in vitro Cu2+-induced lipoprotein oxidation in human serum is preserved in heated garlic: effect unrelated to Cu2+-chelation. | 2004 Sep 1 |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/29266336
cisplatin-induced nephrotoxicity in rats: diallyl sulfide (DAS) was given at two dose levels; 50 and 100 mg/kg, orally for 4 consecutive days, starting one hour after administration of single dose of cisplatin (3.5 mg/kg, i.p.).
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/22397993
Diallyl sulfide (DAS), diallyl disulfide (DADS) and diallyl trisulfide (DATS) at 25 μM for 24-h and 48-h incubations promoted expression of drug resistant genes in colo 205 human colon cancer cells. Cells were treated with 25 uM DAS, DADS and DATS for 24 and 48 h and gene expression levels in colo 205 cells were determined for MRP1, MRP3, MRP4 and MRP6. Results indicated that DAS and DADS enhanced Mdr3 gene expression at the 48-h treatment, but did not affect MRP1, MRP4 and MRP6 gene expression in colo 205 cells. However, DAS and DADS inhibited the gene expressions of MRPs at 24 and 48-h treatment, and both inhibited MRP3 at 24-h treatment and inhibited MRP4 at 48 h treatment in colo 205 cells.
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 19:12:51 GMT 2023
by
admin
on
Fri Dec 15 19:12:51 GMT 2023
|
Record UNII |
60G7CF7CWZ
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C68520
Created by
admin on Fri Dec 15 19:12:51 GMT 2023 , Edited by admin on Fri Dec 15 19:12:51 GMT 2023
|
||
|
JECFA EVALUATION |
ALLYL SULFIDE
Created by
admin on Fri Dec 15 19:12:51 GMT 2023 , Edited by admin on Fri Dec 15 19:12:51 GMT 2023
|
||
|
CFR |
21 CFR 172.515
Created by
admin on Fri Dec 15 19:12:51 GMT 2023 , Edited by admin on Fri Dec 15 19:12:51 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
209-775-1
Created by
admin on Fri Dec 15 19:12:51 GMT 2023 , Edited by admin on Fri Dec 15 19:12:51 GMT 2023
|
PRIMARY | |||
|
17376
Created by
admin on Fri Dec 15 19:12:51 GMT 2023 , Edited by admin on Fri Dec 15 19:12:51 GMT 2023
|
PRIMARY | RxNorm | ||
|
60G7CF7CWZ
Created by
admin on Fri Dec 15 19:12:51 GMT 2023 , Edited by admin on Fri Dec 15 19:12:51 GMT 2023
|
PRIMARY | |||
|
1636800
Created by
admin on Fri Dec 15 19:12:51 GMT 2023 , Edited by admin on Fri Dec 15 19:12:51 GMT 2023
|
PRIMARY | |||
|
DTXSID6060470
Created by
admin on Fri Dec 15 19:12:51 GMT 2023 , Edited by admin on Fri Dec 15 19:12:51 GMT 2023
|
PRIMARY | |||
|
m1558
Created by
admin on Fri Dec 15 19:12:51 GMT 2023 , Edited by admin on Fri Dec 15 19:12:51 GMT 2023
|
PRIMARY | Merck Index | ||
|
C038491
Created by
admin on Fri Dec 15 19:12:51 GMT 2023 , Edited by admin on Fri Dec 15 19:12:51 GMT 2023
|
PRIMARY | |||
|
592-88-1
Created by
admin on Fri Dec 15 19:12:51 GMT 2023 , Edited by admin on Fri Dec 15 19:12:51 GMT 2023
|
PRIMARY | |||
|
20947
Created by
admin on Fri Dec 15 19:12:51 GMT 2023 , Edited by admin on Fri Dec 15 19:12:51 GMT 2023
|
PRIMARY | |||
|
105
Created by
admin on Fri Dec 15 19:12:51 GMT 2023 , Edited by admin on Fri Dec 15 19:12:51 GMT 2023
|
PRIMARY | |||
|
7333
Created by
admin on Fri Dec 15 19:12:51 GMT 2023 , Edited by admin on Fri Dec 15 19:12:51 GMT 2023
|
PRIMARY | |||
|
11617
Created by
admin on Fri Dec 15 19:12:51 GMT 2023 , Edited by admin on Fri Dec 15 19:12:51 GMT 2023
|
PRIMARY | |||
|
C68524
Created by
admin on Fri Dec 15 19:12:51 GMT 2023 , Edited by admin on Fri Dec 15 19:12:51 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> ACTIVE CONSTITUENT ALWAYS PRESENT | |||
|
PARENT -> ACTIVE CONSTITUENT ALWAYS PRESENT | |||
|
METABOLIC ENZYME -> INHIBITOR |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE -> PARENT |
|